2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Innate Inflammatory Response in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behrens, S; Chang-Claude, J; Flesch-Janys, D; Jaskulski, S; Johnson, T; Jung, AY; Kaaks, R; Sookthai, D; Thöne, K | 1 |
| Abrahamsson, A; Dabrosin, C; Lindahl, G | 1 |
| Berk, K; Chabowski, A; Charytoniuk, T; Drygalski, K; Harasim-Symbor, E; Iłowska, N; Konstantynowicz-Nowicka, K; Łukaszuk, B | 1 |
| Eichholzer, M; Linseisen, J; Nicastro, HL; Platz, EA; Richard, A; Rohrmann, S | 1 |
| Bruun, JM; Bügel, S; Hallund, J; Tetens, I; Tholstrup, T | 1 |
1 trial(s) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Innate Inflammatory Response
| Article | Year |
|---|---|
The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women.
Topics: 4-Butyrolactone; Biomarkers; C-Reactive Protein; Cross-Over Studies; Double-Blind Method; Female; Flax; Humans; Inflammation; Lignans; Middle Aged; Phytoestrogens; Postmenopause; Time Factors | 2008 |
4 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Innate Inflammatory Response
| Article | Year |
|---|---|
Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.
Topics: 4-Butyrolactone; Aged; Biomarkers; Breast Neoplasms; Case-Control Studies; Disease-Free Survival; Female; Humans; Inflammation; Lignans; Middle Aged; Postmenopause; Prognosis; Proportional Hazards Models; Prospective Studies | 2018 |
Dietary flaxseed and tamoxifen affect the inflammatory microenvironment in vivo in normal human breast tissue of postmenopausal women.
Topics: 4-Butyrolactone; Breast; Breast Neoplasms; Diet; Estrogen Antagonists; Female; Flax; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-18; Interleukin-1beta; Interleukin-8; Lignans; Matrix Metalloproteinase 9; Microdialysis; Middle Aged; Postmenopause; Seeds; Tamoxifen; Tumor Microenvironment | 2019 |
The effect of enterolactone on liver lipid precursors of inflammation.
Topics: 4-Butyrolactone; Eicosanoids; Fatty Acids; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Hep G2 Cells; Hepatocytes; Humans; Inflammation; Lignans; Lipid Metabolism; Lipids; Liver; Palmitic Acid; Prostaglandins; Triglycerides | 2019 |
Urinary lignans and inflammatory markers in the US National Health and Nutrition Examination Survey (NHANES) 1999-2004 and 2005-2008.
Topics: 4-Butyrolactone; Adult; Aged; Biomarkers; C-Reactive Protein; Chronic Disease; Cross-Sectional Studies; Female; Humans; Inflammation; Leukocyte Count; Lignans; Male; Middle Aged; Nutrition Surveys; United States | 2014 |